Page last updated: 2024-12-08

5'-deoxy-5'-iodouridine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

5'-deoxy-5'-iodouridine: RN given refers to unlabeled cpd; main heading IDOXURIDINE refers to 2'-deoxy-5-iodouridine [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID188325
SCHEMBL ID784429
MeSH IDM0095137

Synonyms (17)

Synonym
5'-deoxy-5'-iodouridine
5'-iodo-5'-deoxyuridine
14259-58-6
1-[(2r,3r,4s,5s)-3,4-dihydroxy-5-(iodomethyl)oxolan-2-yl]pyrimidine-2,4-dione
uridine, 5'-deoxy-5'-iodo-
5'-iodo-2'deoxyuridine
SCHEMBL784429
5'-iod-uridine
DTXSID40162095
AKOS027339889
5??-deoxy-5??-iodouridine
1 -((2r,3r,4s,5 s)-3,4-dihydroxy-5 -iodomethyl-tetrahydro-furan-2-yl)-1h-pyrimidine-2,4-dione
mfcd23160104
5/'-deoxy-5/'-iodouridine
F12674
1-((2r,3r,4s,5s)-3,4-dihydroxy-5-(iodomethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione
CS-14452

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" This work led us to propose a model in which the human DNA helicase RECQ1 acts as a governor of the single-stranded DNA binding protein RPA and regulates its bioavailability for DNA synthesis."( Single-Molecule DNA Fiber Analyses to Characterize Replication Fork Dynamics in Living Cells.
Banerjee, T; Brosh, RM; Datta, A; Dhar, S, 2019
)
0.51
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Pathways (1)

PathwayProteinsCompounds
salvage pathways of pyrimidine ribonucleotides936

Research

Studies (79)

TimeframeStudies, This Drug (%)All Drugs %
pre-199067 (84.81)18.7374
1990's0 (0.00)18.2507
2000's2 (2.53)29.6817
2010's10 (12.66)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.39

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.39 (24.57)
Research Supply Index4.41 (2.92)
Research Growth Index4.80 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.39)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (1.23%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other80 (98.77%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]